Role of Levofloxacin in the Treatment of Lower Respiratory Tract Infections | Infection Update

Role of Levofloxacin in the Treatment of Lower Respiratory Tract Infections

21 June, 2018

ball

Role of Levofloxacin in the Treatment of Lower Respiratory Tract Infections

Peter Ball, FRCP (Ed)

Question

Q 1.		Bacterial etiology of lower respiratory tract infections
Q 2.		Antibacterial activity of levofloxacin
Q 3.		Changing guideline recommendations
Q 4.		Levofloxacin in community-acquired pneumonia trials
Q 5.		Levofloxacin: optimal treatment duration
Q 6.		Early treatment of community-acquired pneumonia
Q 7.		IV-PO switch therapy
Q 8.		Cost-effectiveness of IV-PO switch
Q 9.		Levofloxacin in treatment of acute exacerbations of chronic bronchitis
Q10.		Safety profile of levofloxacin
Q11.		Structure-adverse event relationships among fluoroquinolones
Q12.		Fluoroquinolone class effects and relative adverse drug reaction rates
Q13.		Levofloxacin and other fluoroquinolones: severity of side effects
Q14.		Merits of post-marketing surveillance data

LATEST TOPICS